Guangzhou Baiy | 600332 - Cash And Equivalent


Guangzhou Baiy reported CNY12.33B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Aspen Pharmacare ZAR 5.62B 789M Dec/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Kalbe Farma IDR 4.05T 245.07B Sep/2025
Richter Gedeon HUF 135.63B 61.59B Dec/2024
Sh Fosun Pharma CNY 13.1B 1.63B Dec/2025
Sh Pharmaceutical CNY 36.73B 2.36B Sep/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
Teva Pharmaceutical Industries USD 3.56B 1.35B Dec/2025